Monument, MD-Led Platform

Monument is a New York-based telehealth company founded in 2019 with a mission to make effective alcohol use disorder treatment as accessible as possible. The company operates at the intersection of medication-assisted treatment (MAT), evidence-based therapy, and peer community support — a combination that mirrors the clinical gold standard for AUD treatment (behavioral therapy plus pharmacotherapy) but delivers it entirely through a virtual platform. Monument's physician prescribers offer naltrexone and disulfiram as medication options. Naltrexone reduces alcohol cravings by blocking opioid receptors involved in alcohol's reward response, and is typically prescribed as a daily oral tablet or as Vivitrol (monthly injection). Disulfiram creates aversive reactions if alcohol is consumed, functioning as a deterrent. Both medications are FDA-approved for alcohol use disorder and are prescribed after a video consultation with a Monument physician who reviews the patient's complete health history, current medications, and liver function. The therapy component connects patients with licensed therapists who specialize in alcohol use disorder. Sessions are conducted weekly via video and are grounded in evidence-based approaches including cognitive behavioral therapy (CBT) and motivational interviewing (MI). Monument therapists do not provide general mental health therapy — they specialize exclusively in alcohol treatment, which allows for more focused, relevant care than a generalist therapist would provide. Beyond physician and therapy appointments, Monument offers an anonymous community forum and therapist-moderated support groups accessible 24/7. These group-based elements add a peer support dimension that research consistently links to improved recovery outcomes, without requiring patients to attend in-person AA or SMART Recovery meetings. Monument accepts major commercial insurance including United Healthcare, Cigna, Aetna, and Anthem, and the per-visit cost for insured patients is typically $25. The platform currently operates in 18 states: Arizona, California, Colorado, Connecticut, Washington DC, Florida, Georgia, Iowa, Kentucky, New Jersey, New York, Ohio, Oregon, Pennsylvania, South Carolina, Texas, Virginia, and Washington. Patients with severe physical alcohol dependence requiring medically supervised detox are advised to seek inpatient or intensive outpatient care before enrolling. AUD treatment (behavioral therapy plus pharmacotherapy) but delivers it entirely through a virtual platform. Monument's physician prescribers offer naltrexone and disulfiram as medication options. Naltrexone reduces alcohol cravings by blocking opioid receptors involved in alcohol's reward response, and is typically prescribed as a daily oral tablet or as Vivitrol (monthly injection). Disulfiram creates aversive reactions if alcohol is consumed, functioning as a deterrent. Both medications are FDA-approved for alcohol use disorder and are prescribed after a video consultation with a Monument physician who reviews the patient's complete health history, current medications, and liver function. The therapy component connects patients with licensed therapists who specialize in alcohol use disorder. Sessions are conducted weekly via video and are grounded in evidence-based approaches including cognitive behavioral therapy (CBT) and motivational interviewing (MI). Monument therapists do not provide general mental health therapy — they specialize exclusively in alcohol treatment, which allows for more focused, relevant care than a generalist therapist would provide. Beyond physician and therapy appointments, Monument offers an anonymous community forum and therapist-moderated support groups accessible 24/7. These group-based elements add a peer support dimension that research consistently links to improved recovery outcomes, without requiring patients to attend in-person AA or SMART Recovery meetings. Monument accepts major commercial insurance including United Healthcare, Cigna, Aetna, and Anthem, and the per-visit cost for insured patients is typically $25. The platform currently operates in 18 states: Arizona, California, Colorado, Connecticut, Washington DC, Florida, Georgia, Iowa, Kentucky, New Jersey, New York, Ohio, Oregon, Pennsylvania, South Carolina, Texas, Virginia, and Washington. Patients with severe physical alcohol dependence requiring medically supervised detox are advised to seek inpatient or intensive outpatient care before enrolling.